SAT-001 数字疗法软件对儿童近视脉络膜厚度的短期调节:一项随机试点研究
Short-term choroidal thickness modulation with SAT-001 digital software intervention in pediatric myopia: a randomized pilot study
SAT-001 数字软件干预可急性调节儿童近视患者的脉络膜厚度。该探索性研究纳入 20 名近视儿童,结果显示 SAT-001 组在应用后可显著增加视网膜下脉络膜厚度(调整 P < 0.05),支持其作为数字疗法短期生理生物标志物的潜力。
- Article
- Open access
- Published: 16 October 2026
- So Young Han1,
- Jarang Hahm2,
- Mi Kyoung Bae2,
- Yong Sun Lee2 &
- …
- Soolienah Rhiu ORCID: orcid.org/0000-0002-9304-15193,4
Scientific Reports (2026) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
Myopia progression in children is associated with excessive axial elongation, leading to structural changes in the eye, including choroidal thinning. This two-center, randomized, open-label, parallel-group, exploratory study aimed to investigate the effects of SAT-001, a software-based digital therapeutic device, and its modified version (mSAT-001) on choroidal thickness (ChT) in pediatric myopia. A total of 20 myopic children (9.00 ± 2.20 years) were divided into two groups. Group 1 (N = 10) used SAT-001, requiring 30 min of device application (structured eye-movements and rest modules), while Group 2 (N = 10) used mSAT-001, requiring 15 min of device application (structured eye-movements only). ChT was measured at the subfoveal and four additional anatomical locations (two nasal, two temporal points from the fovea) in the right eye at baseline, immediately before, and after device application. Both groups showed ChT increases after device application, but Bonferroni-adjusted within-group significance observed only in Group 1. Between-group differences were significant subfoveally and nasally, with subfoveal significance retained in sensitivity analyses (adjusted P < 0.05). These findings suggest that SAT-001 may acutely modulate ChT in children with myopia and support the potential utility of ChT as an exploratory physiological biomarker for evaluating short-term responses to digital therapeutic interventions.
Acknowledgements
The authors thank the following individuals for their valuable technical support, coordination during the clinical trial, and illustration of the figure: Kyung-Hee Kim, Moon-Jeong Kim, Tae-Hyun Kim, and Yu Jeong Lee. In addition, the authors thank to Professor Keunbaik Lee (Sungkyunkwan University, Seoul, Republic of Korea) for valuable comments on repeatability analysis and its results.
Funding
This study was a sponsor-initiated trial funded by S-Alpha Therapeutics, Inc., which manufactured and provided the investigational digital therapeutic devices (SAT-001 and mSAT-001) used in this trial. S-Alpha Therapeutics participated in the design of the study, reproducibility analysis, preparation and review of the manuscript.
Author information
Authors and Affiliations
Department of Ophthalmology, School of Medicine, Sungkyunkwan University, Kangbuk Samsung Hospital, Jongno-gu, Seoul, Republic of Korea
So Young Han
S-Alpha Therapeutics, Inc., Yeongdeungpo-gu, Seoul, Republic of Korea
Jarang Hahm, Mi Kyoung Bae & Yong Sun Lee
Department of Ophthalmology, Hallym University School of Medicine, Dongtan Sacred Heart Hospital, Hwaseong, Gyeonggi-do, Republic of Korea
Soolienah Rhiu
Dongtan Sacred Heart Hospital, Hallym University School of Medicine, 7 Geunjaebong-gil, Hwaseong-si, 18450, Gyeonggi-do, Republic of Korea
Soolienah Rhiu
Authors
- So Young Han
- Jarang Hahm
- Mi Kyoung Bae
- Yong Sun Lee
- Soolienah Rhiu
Corresponding author
Correspondence to Soolienah Rhiu.
Ethics declarations
Competing interests
JH, MKB, and YSL are employees of S-Alpha Therapeutics, Inc. and receive salaries. In addition, YSL hold shares of the company. The other authors declare no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Han, S.Y., Hahm, J., Bae, M.K. et al. Short-term choroidal thickness modulation with SAT-001 digital software intervention in pediatric myopia: a randomized pilot study. Sci Rep (2026). https://doi.org/10.1038/s41598-026-76034-6
Received: 11 April 2026
Accepted: 12 October 2026
Published: 16 October 2026
DOI: https://doi.org/10.1038/s41598-026-76034-6
Keywords
来源:Nature 健康护理主题 · nature.com